Skip to content
2000
Volume 15, Issue 5
  • ISSN: 1570-193X
  • E-ISSN: 1875-6298

Abstract

Noscapine is an opium alkaloid which has been historically used as an anti-tussive medicine. Its activity is attributed to its ability to bind stoichiometrically to tubulin, thus arresting cell division at the metaphase stage and leading to apoptosis. Its action as a safe, low toxicity drug has been confirmed and many different routes of synthesizing its naturally occurring, biologically active (-)-α isomer have been established. While noscapine has many advantages over present anti-cancer drugs - such as low toxicity, safety, high bioactivity (especially against drug-resistant strains of cancer) and oral administration - it faces the drawback of requiring a large Effective Dose (ED50) to show significant bioactivity. The analogues of noscapine show much higher activity, making these compounds more desirable as anti- cancer agents. This review explores in-depth the chemistry of noscapine and its analogues synthesized till date, including brief discussions about the bioactivity of different derivatives. In the coming years, noscapine and its analogues will present an exciting avenue for cancer therapeutics.

Loading

Article metrics loading...

/content/journals/mroc/10.2174/1570193X15666180221153911
2018-10-01
2025-07-11
Loading full text...

Full text loading...

/content/journals/mroc/10.2174/1570193X15666180221153911
Loading

  • Article Type:
    Review Article
Keyword(s): anti-cancer drugs; benzazepine; cancer; drug discovery; Noscapine; synthesis
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test